redalpine Backs Hypervision Surgical’s £17M Series A

redalpine has joined the £17 million Series A round for Hypervision Surgical, a King's College London spinout developing real-time hyperspectral imaging technology for surgery. Led by Heal Capital, the round also includes healthcare specialists and strategic investors, reflecting strong confidence in the company's ability to improve surgical decision-making and patient outcomes.

The funding will accelerate commercial rollout of Hypervision Surgical's HYPERSNAP system and expand clinical adoption of its next-generation sensing technology. For redalpine, the investment underscores its commitment to backing high-impact medtech businesses emerging from deep scientific and clinical innovation.

https://medtechinnovator.org/investors-inject-17m-into-kings-college-london-medical-spinout-hypervision-surgical/